ProSynth is a UK based world renowned Custom Research Organisation (CRO) providing confidential, highly specialized, mission critical chemistry and route to molecule services. ProSynth clients derive from a variety of industries including pharmaceutical & biotech drug discovery organisations, electronics & semiconductor equipment multinationals, and branded consumer products companies.
Established in 1992 as a supplier of organic intermediates offered by traditional catalogue vendors, ProSynth subsequently progressed into the development and production of complex and proprietary intermediates.

ProSynth has since evolved into an elite custom synthesis services provider and supplier of advanced client mandated intermediates with a reputation for scientific excellence and precision synthesis.

ProSynth is well known to multinational pharmaceutical and emerging biotech organisations providing confidential custom synthesis services, developing routes to new molecules and medicinal chemistry support. ProSynth has developed several strategic alliances with Chemistry Manufacturing Control (CMC) Project Managers to enable the seamless project transfer to Good Manufacturing Practise (GMP) manufacturers in line with client objectives.

ProSynth provides specialized material science services to the organic electronics industry including the development and production of ultra-high purity intermediates and finished products for a comprehensive range of applications.

In 2016 ProSynth was recognised on HM The Queen’s 90th Birthday as one of the select winners of the Queens Award for Enterprise – the UK’s highest accolade for business success. Our award was received for growth and commercial success in international trade.

ProSynth offers four main business services: Confidential Mission Critical CRO Custom Synthesis, Organic Electronics, Medicinal Chemistry Support and Novel Intermediates.

Howard Craven, Managing Director of Prosynth, leads our dedicated and talented team of professional chemists.